Can endometrial arylsulfatase A activity predict the onset of endometrial polyps over the years?

A atividade da arilsulfatase endometrial A pode prever a aparição de pólipos endometriais ao longo dos anos?

ARTIGOS ORIGINAIS

Can endometrial arylsulfatase A activity predict the onset of endometrial polyps over the years?

A atividade da arilsulfatase endometrial A pode prever a aparição de pólipos endometriais ao longo dos anos?

Ugo Indraccolo^I; Maria Matteo^II; Carla Bracalenti^III; Pantaleo Greco^II; Salvatore Renato Indraccolo^IV

^IComplex Operative Unit of Gynecology and Obstetrics, Hospital of Civitanova Marche – Area Vasta 3 – Marche, Italy

^IIInstitute of Obstetrics and Gynecology, Department of Surgical Sciences, University of Foggia, Italy

^IIIDepartment of Clinical Pathology, Operative Unit of Pathology, Hospital of Macerata, Area Vasta 3 – Marche, Italy

^IVDepartment of Gynecological, Obstetrical, and Urological Sciences "La Sapienza", University of Rome, Italy

^{Correspondence}

ABSTRACT

PURPOSE: To assess if arylsulfatase A activity (ASA) and sulfatide (SL) concentration in the human endometrium can be predictive of the development of endometrial polyps over the years, since ASA activity reflects the endometrial sensitivity to hormones.

METHODS: ASA activity and SL concentration were determined by biochemical procedures on endometrial samples collected between 1990 and 1994 in non-menopausal women. These women underwent a new endometrial sampling following the clinical indication some years after the first endometrial sampling. The histological assessment of the second endometrial specimens found four patients with normal endometrial pattern and 10 patients with one or more endometrial polyps. ASA activity/years elapsed and SL concentration/years elapsed were compared using two tailed Mann-Whitney test for unpaired data between patients with normal pattern and patients with endometrial polyps.

RESULTS: Median ASA activities were 2.62 (normal pattern) versus 1.85 (endometrial polyps) nmol hydrolized substrate/min. Median activity/years elapsed is higher in patients with second endometrial sample presenting normal pattern (p=0.006) and median SL concentration/years elapsed does not differ significantly among groups, even if median SL concentration seems to be higher in patients who subsequently developed polyps (1031 µg/g of fresh tissue versus 341,5 µg/g of fresh tissue).

CONCLUSIONS: ASA activity can predict the onset of endometrial polyps over the years.

Keywords: Arylsulphatase A; Polyps; Endometrium; Gonadal steroid hormones; Sulphatides; Endometrium

RESUMO

OBJETIVO: Avaliar se a atividade da arilsulfatase A (ASA) e a concentração de sulfatida (SL) no endométrio humano pode ser preditivo em relação ao desenvolvimento de pólipos endometriais ao longo dos anos, posto que atividade da ASA reflete a sensibilidade do endométrio aos hormônios.

MÉTODOS: A atividade da ASA, assim como a concentração de SL, foi determinada por meio de procedimentos bioquímicos em amostras de endométrio coletadas entre 1990 e 1994, em mulheres que não se encontravam na menopausa. Essas mulheres foram submetidas a uma nova amostragem endometrial após indicação clínica alguns anos depois da primeira amostragem endometrial. A avaliação histológica dos segundos espécimes endometriais permitiu identificar quatro pacientes com padrão endometrial normal e 10 com um ou mais pólipos endometriais. A atividade da ASA/anos depois e a concentração de SL/anos depois foram comparadas, utilizando o teste bilateral U de Mann-Whitney para dados não pareados entre as pacientes com padrão normal e as pacientes com pólipos endometriais.

RESULTADOS: A ativitade da ASA foi 2,62 (padrão normal) em comparação com 1,85 (endometrial pólipos) de substrato hidrolisado/min. A atividade da ASA/anos depois é maior em pacientes com segunda amostra endometrial a apresentarem um padrão normal (p=0,006), e a concentração mediana de SL/anos depois não difere de forma significativa entre os grupos, apesar de a concentração mediana de SL parecer maior em pacientes que posteriormente desenvolveram pólipos (1031 µg/g de tecido fresco em comparação com 341,5 µg/g de tecido fresco).

CONCLUSÕES: A atividade da ASA pode prever a aparição de pólipos endometriais ao longo dos anos.

Palavras-chave: Cerebrosídeo sulfatase; Pólipos; Endométrio ; Hormonios esteroides gonadais; Sulfatidas; Endométrio

Introduction

Endometrial behavior during the menstrual cycle is closely related to the expression of hormonal receptors in the glandular epithelium and stroma¹. As opposed to patients with normal cycles, patients with dysfunctional bleeding have higher levels of estrogen receptors in the second phase of the cycle², which suggests that their endometrium is more susceptible to estrogen stimulation.

It is thought that endometrial polyps may be related in some ways to hyperestrogenism both in premenopausal and postmenopausal patients³. Therefore, patients with dysfunctional bleeding, more sensitive to estrogens², may develop endometrial polyps over the years in relation to endometrial estrogen sensitivity and to the duration of estrogen stimulation of endometrium.

Many genes are expressed in the endometrium during the menstrual cycle in relation to hormonal stimulation, with the goal to prepare the endometrium for implantation⁴. Arylsulphatase A (ASA) expression is regulated by estrogens and progesterone, because estrogens decrease ASA activity and

progesterone increases it^5-8. ASA is a lysosomal enzyme that catabolizes sulphatides (SL). To date, it is not known what role SL plays in the physiology of the endometrium.

The objective of this study is to evaluate whether ASA activity and SL concentration can predict the onset of endometrial polyps over the years, because hormonal control of ASA activity is a marker of endometrial hormonal sensitivity.

Methods

Starting in 1990, a study on endometrial specimens collected at the Obstetrics School of Camerino (Italy) was initiated. The research aimed to assess ASA activity and SL concentration in normal endometrium through the endometrial cycle and in endometrial pathologies, and results were published in 1992 and 1994^6,9. Such analyses were previously approved by local ethics committees. Among samples collected between 1990 and 1994, some cases were excluded from data published in 1992 and 1994^6,9 because patients did not meet the inclusion criteria. However, ASA activity and SL concentration were nonetheless assessed on such specimens.

The names and birth dates of the excluded non-menopausal patients and the names and birth dates of non-menopausal patients enrolled in previous studies^6,9 were transmitted to the Operative Unit of Pathology of the hospital of Macerata (Area Vasta 3 – 3 Marche). Here, it was observed whether or not some of these patients had undergone another endometrial biopsy, collected between 1995 and 2011. Therefore, this is a retrospective study. The search retrieved 14 cases, four of which had normal endometrium, and 10 of which had endometrial polyps.

ASA activity and SL concentration analyzed on endometrial specimens collected from 1990 and 1994 were compared in the group of patients with negative endometrium in the subsequent endometrial samples and in the group of patients who developed endometrial polyps. To control the effect of time (years) between the first and the second endometrial sample, ASA activity and SL concentration were divided by the years elapsed between the two samplings, to obtain an index for statistical analysis. Two tailed Mann-Whitney test for unpaired data was used for statistical analysis, with p<0.05 as the minimum for significance. Kyplot 2.0 was used for statistical analysis.

The specimens collected from 1990 to 1994 were obtained after dilatation and curettage (D&C). A portion of each sample was processed for histological diagnosis; the other portion was stored at -20°C. Extraction and separation of sulfatides were carried out according to a method adapted from Bolognani et al.¹⁰: The samples were homogenized in chloroform/methanol (2:1 w/v) and the extract was filtered though a sintered glass with a vacuum pump connection. KCl (0.88%) was added to the filtrate and, after stirring, the covered tube was left until the separation phase (aqueous and organic phase) occurred. The organic phase was analyzed by means of a spectrophotometric procedure for sulfatides, using a 0.15 mm Azure A solution in 0.05 N H2SO4 for staining¹¹. Absorbance was measured at 640 nm against a standard containing 70 mg/g of sulfatides. Concentration was expressed as µg/g of fresh tissue.

The organic phase was also used for thin layer chromatography (TLC) separation on a 0.25 mm silica gel plate. Lipids were separated on the same plate using a solvent mixture of chloroform-methanol-water (70:30:5 per volume) and compared with a standard polar lipid mixture (phosphatidylcholine, sulfatides, phosphatidylethanolamine and cerebrosides). The plates were exposed to iodine vapours to visualize the lipid fractions in order to quantify sulfatide concentration.

To assess ASA activity, samples were homogenized for 2 minutes in double distilled water (1:20 w/v) containing 0.1% Triton versus 100 with Ultraturrax TP 18/10 homogenizer (Janke & Kunkel, Staufen, Germany). The homogenate was centrifuged at 20,000 rpm at 4°C for 30 minutes using a refrigerated centrifuge (IEC Centra SR, Dunstable, Bedfordshire, England). ASA activity was determined biochemically according to a method by Vitaioli et al.¹², adapted from Percy and Brady¹³. The incubation mixture consisted of 0.01 M p-nitrocatechol sulfate in 0.5 mM sodium acetate buffer at pH 5.0 containing mM Na₄P₂O₇, and 10% w/v NaCl, and 10–50 mg of protein. The mixture was incubated at 37°C and the reaction stopped after 30 minutes by adding 1 N NaOH. The absorbance of a reaction product, p-nitrocatechol, was measured at 515 nm against a blank using a Beckman DU 40 spectrophotometer (Irvine, USA). The specific activity was expressed as nmol hydrolysed substrate/min per mg protein, assuming 14.0 x 10³ as the molar extinction coefficient for the hydrolysis product, p-nitrocatechol, of the substrate at 515 nm. Protein concentrations were measured according to the Bradford's¹⁴ method.

P-nitrocathecol sulfate and standard polar lipids mixture were purchased from Sigma Aldrich Chemical Co. (St. Louis, MO). All other chemicals were of analytical grade and were purchased from Serva (Heidelberg, Germany). The 0.25 mm precoated silica gel plates, used for TLC, were purchased from Merck Co. (Dormstadt, Germany).

Endometrial samples taken between 1995 and 2011 were obtained from hysteroscopic biopsies as a routine endometrial assessment for irregular bleeding or ultrasonographic suspicion of endometrial diseases within the entire health district of Area Vasta 3 – Marche.

Results

Table 1 summarizes histological diagnoses for the first and second endometrial specimens. Additionally, Table 1 reported the patient's age at the first endometrial sampling and the years elapsed from first sampling to second. ASA activities and SL concentrations reported in Table 1 are the mean of four determinations for each patient.

Median ASA activity in patients with the second endometrial sample resulting in normal pattern was 2.6 nmol hydrolized substrate/min (limits: 2.28–3.23). Median ASA activity in patients with the second endometrial sample diagnosed as endometrial polyp was 1.85 nmol hydrolized substrate/min (limits: 0.6–3.4). A box-plot describing ASA activities in both groups of patients is represented in Figure 1. After correction for years elapsed from the first and the second endometrial sampling, median ASA activity/years elapsed is higher in patients with the second endometrial sampling resulting in normal pattern (p=0.006).

Median SL concentration in patients with second endometrial sample resulting in normal pattern was 341.5 µg/g of fresh tissue (limits: 300–536). Median SL concentration in patients with the second endometrial sample diagnosed with endometrial polyp was 1,031 µg/g of fresh tissue (limits: 263–1081). A box-plot describing SL concentrations in both group of patients is represented in Figure 2. Median SL concentration/years elapsed does not differ significantly between groups, even if the mean concentration of SL seems to be greater in patients who subsequently developed polyps.

Discussion

Hyperestrogenism as the cause of endometrial polyps is a common belief in the international literature³, even if the cause of the onset of endometrial polyp is still unknown¹⁵. It should be considered that tissue sensitivity to estrogens is related to the expression of estrogen receptors alpha and beta. As reported by Ye et al.¹⁶, the overexpression of estrogen receptor beta may lead to the formation of endometrial polyps.

The expression of estrogen receptors is modulated by endometrial pulsed stimulation of estrogens in postmenopause¹⁷. Moreover, aging alters estrogen sensitivity as well^18-20. It is also reported¹⁶ that estrogen receptor beta is directly related to estrogen levels in serum. Therefore, hyperestrogenism could lead to the onset of endometrial polyps acting on the relative expression

of estrogen receptor beta over the years. We hypothesize that ASA activity is linked with the overall effect of estrogen receptors beta, alpha, and progesterone receptors. A relative abundance of estrogen receptors beta physiologically prevents the expression of estrogen receptor alpha and, consequently, of progesterone receptors²¹. Therefore, in patients that further develop endometrial polyps, a less intense activity of ASA should be found as a sign of less intense sensitivity to progesterone. The ASA activity reported in our data should be strictly related to estrogen receptor alpha/beta ratio. Therefore, ASA activity predicts the formation of endometrial polyps over the years, because a chronically irregular estrogen stimulation of the endometrium leads to the formation of endometrial polyps³. After correcting the ASA activity values by years elapsed from the first to the second endometrial sampling, it is demonstrated that ASA activity predicts the onset of endometrial polyps.

Interestingly, the SL concentration does not seem to be related to the formation of endometrial polyps. As demonstrated in Figure 2, however, data are dispersed, leading to difficulties to interprete the results. However, a dispersion of SL concentrations in decidua and fetal adnexa was previously found^22,23, thus suggesting that the turnover of SL may be related to other control mechanisms involving both biosynthesis and catabolism. Therefore, steroids may control the SL turnover in many unknown ways overall.

The major limitation of this study is the small sample of followed-up patients. Due to this small sample size, readers must be cautious to interprete the results as being conclusive. Moreover, the sample size may justify the lack of findings about the SL behaviour. We are not able to follow-up more patients, because the endometrial samples were collected with other goals, and, consequently, many patients were lost to follow-up. Therefore, readers should consider those findings as post-hoc results, suggesting further investigations about the behaviour of ASA in the pathophysiology of the human endometrium.

Additionally, this study does not assess steroid receptor expression in relation to ASA activity and SL concentration behavior. This is a limiting factor if one wants to support the hormonal hypothesis of ASA activity control. We were unable to check the steroid receptors expression in the endometrial specimens. However, previous data widely suggested that ASA activity is enhanced by progesterone^5,6,22,23.

In conclusion, the results suggest that ASA activity may predict the formation of endometrial polyps over the years, because it is a marker of lack of endometrial progesterone sensitivity.

Acknowledgments

To Professor Lucia Vitaioli, who allowed the biochemical determination of the specimens between 1990 and 1994 in the Department of Comparative Morphological and Biochemical Sciences, University of Camerino, Italy.

Received 24/09/12

Accepted with modifications 07/11/12

Financial support: none

Results were found from samples collected at the Obstetrics School of Camerino. This institution closed in 1997, therefore the address cannot be supplied.

• 1. Henriet P, Gaide Chevronnay HP, Marbaix E. The endocrine and paracrine control of menstruation. Mol Cell Endocrinol. 2012;358(2)197-207.
• 2. Gleeson N, Jordan M, Sheppard B, Bonnar J. Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding. Eur J Obstet Gynecol Reprod Biol. 1993;48(3):207-14.
• 3. McCluggage WG. Miscellaneous disorders involving the endometrium. Semin Diagn Pathol. 2010;27(4):287-310.
• 4. Haouzi D, Dechaud H, Assou S, De Vos J, Hamamah S. Insights into human endometrial receptivity from transcriptomic and proteomic data. Reprod Biomed Online. 2012;24(1):23-34.
• 5. Vitaioli L, Gobbetti A, Baldoni E. Arylsulphatase A activity and sulphatide concentration in the female rabbit oviduct are under physiological hormonal influence. Histochem J. 1996;28(2):149-56.
• 6. Vitaioli L, Baldoni E, Cecchi A, Indraccolo SR. Menstrual cycle-associated changes of sulphatides and arylsulphatase A activity in human uterine endometrium. Ital J Gynaecol Obstet. 1992;4(1):1-4.
• 7. Munakata H, Isemura M, Yosizawa Z. Hormonal effects on the activities of glycosidases in the endometrium of rabbit uterus. Biochem Med Metab Biol. 1986;35(2):179-83.
• 8. Kamei K, Kubushiro K, Fujii T, Tsukazaki K, Nozawa S, Iwamori M. Menstrual cycle-associated regulation of anabolic and catabolic enzymes causes luteal phase-characteristic expression of sulfatide in human endometrium. Am J Obstet Gynecol. 1997;176(1 Pt 1):142-9.
• 9. Vitaioli L, Baldoni E, Ricci R, Indraccolo SR. Expression of acidic glycosphingolipids and arylsulphatase A activity in human pathological endometrium. Eur J Obstet Gynecol Reprod Biol. 1994;54(1):31-5.
• 10. Bolognani L, Masserini M, Bodini PA, Bolognani Fantin AM, Ottaviani E. Lipid composition in ganglia of Mollusca. J Neurochem. 1981;36(3):821-5.
• 11. Kean EL. Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. J Lipid Res. 1968;9(3):319-27.
• 12. Vitaioli L, Baldoni E, Bellini-Cardellini L. Arylsulphatase activity in the frog oviduct during the recovery phase of the reproductive cycle. Cell Mol Biol. 1986;32(2):187-93.
• 13. Percy AK, Brady RO. Metachromatic leukodystrophy: diagnosis with samples of venous blood. Science. 1968;161(3841):594-5.
• 14. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
• 15. Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol. 2011;18(5):569-81.
• 16. Ye H, Xu XR, Liu YK, Liu ZH, Zhao AZ. Study on the relationship between estrogen receptor beta and etiology of human endometrial polyps. Zhonghua Fu Chan Ke Za Zhi. 2006;41(12):814-6. Chinese.
• 17. Kenemans P, Genazzani AR, Palacios S, Schneider HP. Pulsed estrogen exposure selectively modulates tissue response: a hypothesis. Gynecol Endocrinol. 2004;18(3):159-64.
• 18. Han Z, Kokkonen GC, Roth GS. Effect of aging on populations of estrogen receptor-containing cells in the rat uterus. Exp Cell Res. 1989;180(1):234-42.
• 19. McCormack SA, Glasser SR. Differential response of individual uterine cell types from immature rats treated with estradiol. Endocrinology. 1980;106(5):1634-49.
• 20. Nephew KP, Long X, Osborne E, Burke KA, Ahluwalia A, Bigsby RM. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod. 2000;62(1):168-77.
• 21. Hertrampf T, Seibel J, Laudenbach U, Fritzemeier KH, Diel P. Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats. Br J Pharmacol. 2008;153(7):1432-7.
• 22. Baldoni E, Traini E, Tomassoni D, Indraccolo U, Indraccolo SR, Vitaioli L. Biochemical determinations of arylsulphatase A activity and sulphatide concentrations in decidua of women at 41 and 42 weeks of gestation. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):24-8.
• 23. Indraccolo U, Traini E, Baldoni E, Indraccolo SR, Vitaioli L. Arylsulphatase A activity and sulphatide concentration in placenta, membranes and cord after delivery. J Perinat Med. 2009;37(5): 497-502.

Correspondence

Ugo Indraccolo, M.D., Ph.D.

Loc. Montagnano 16

62032 Camerino (MC), Italy

Publication Dates

• Publication in this collection
  11 Jan 2013
• Date of issue
  Jan 2013

History

• Received
  24 Sept 2012
• Accepted
  07 Nov 2012